Spero Therapeutics, Inc. (SPRO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:41PM EST. Market open.
| Previous close | 1.2600 |
| Open | 1.2500 |
| Bid | 1.2700 x 800 |
| Ask | 1.2800 x 1000 |
| Day's range | 1.2500 - 1.3000 |
| 52-week range | 0.9900 - 2.0400 |
| Volume | |
| Avg. volume | 175,158 |
| Market cap | 67.426M |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | 3.26 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript November 13, 2023 Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.15. Ted Jenkins: Thank you, operator, and thank you all for participating in today’s conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the third […]
- Zacks
All You Need to Know About Spero Therapeutics, Inc. (SPRO) Rating Upgrade to Buy
Spero Therapeutics, Inc. (SPRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
Spero Therapeutics, Inc. (SPRO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Spero Therapeutics, Inc. (SPRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
© 2023 Yahoo. All rights reserved.